Immunitybio Inc
NASDAQ:IBRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immunitybio Inc
NASDAQ:IBRX
|
US |
|
Abcam PLC
LSE:ABC
|
UK |
|
BBTV Holdings Inc
TSX:BBTV
|
CA |
|
Virtual Global Education Ltd
BSE:534741
|
IN |
|
Ermenegildo Zegna NV
NYSE:ZGN
|
IT |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
IE |
|
L
|
Lingkaran Trans Kota Holdings Bhd
KLSE:LITRAK
|
MY |
|
M
|
Menivim The New REIT Ltd
TASE:MNRT
|
IL |
|
EGPI Firecreek Inc
OTC:EFIR
|
US |
|
China Sun Group High-Tech Co
OTC:CSGH
|
CN |
|
Zhejiang Meilun Elevator Co Ltd
SSE:603321
|
CN |
|
Louisiana-Pacific Corp
NYSE:LPX
|
US |
|
Z
|
Zenotech Laboratories Ltd
BSE:532039
|
IN |
Bankruptcy Probability
Immunitybio Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Immunitybio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Immunitybio Inc
NASDAQ:IBRX
|
7.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
174.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
66.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Immunitybio Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Immunitybio Inc has total debt of 801.7m USD. This includes both short-term (0 USD) and long-term (801.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
